D. Çakan, Semih Uşaklıoğlu
{"title":"Relationship Between Smell Disorders and Pulmonary Involvement in COVID-19","authors":"D. Çakan, Semih Uşaklıoğlu","doi":"10.4274/haseki.galenos.2022.8651","DOIUrl":null,"url":null,"abstract":"Aim: Some symptoms of coronavirus disease-2019 (COVID-19) are more common in patients without pulmonary involvement and in patients with a good prognosis. Although it is known that smelling disorders are more common in patients with a good prognosis, their relationship with pulmonary involvement is unknown. This study ianvestigated the relationship between smell disorders and pulmonary involvement in COVID-19. Method(s): This cross-sectional study was conducted between May 2022 and July 2022 and included 60 COVID-19 patients with pulmonary involvement and 60 COVID-19 patients without pulmonary involvement. Phone-call interviews were performed with all patients 1 month after the diagnosis of COVID-19 and their sense of smell was questioned with a questionnaire. The prevalence of smell disorders, type and severity of smell disorders were questioned, and participants were asked to grade their answers from 0 to 10. Result(s): In 58 (48.3%) of the patients, smell disorders were found to be present. Hyposmia was detected in 35 (60.34%), and anosmia was detected in 23 (39.66%) of these patients. Smell disorder was present in 20 (33.3%) patients with pulmonary involvement and in 38 (63.3%) patients without pulmonary involvement. The prevalence of smell disorders was significantly higher in patients without pulmonary involvement (p=0.001). Hyposmia in 15 patients (25%) and anosmia in 5 patients (8.3%) were found in patients with pulmonary involvement. Hyposmia in 20 patients (33.3%) and anosmia in 5 patients (8.3%) were found in patients without pulmonary involvement. The prevalence of anosmia was significantly higher in patients without pulmonary involvement (p=0.003). The smell disorders were significantly more severe in patients without pulmonary involvement (p=0.042). Conclusion(s): Smell disorders are seen more frequently and more severely in patients without pulmonary involvement due to COVID-19 than in patients with pulmonary involvement. Copyright © 2022 by The Medical Bulletin of Istanbul Haseki Training and Research Hospital The Medical Bulletin of Haseki published by Galenos Yayinevi.","PeriodicalId":42416,"journal":{"name":"Haseki TIp Bulteni-Medical Bulletin of Haseki","volume":"41 1","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Haseki TIp Bulteni-Medical Bulletin of Haseki","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/haseki.galenos.2022.8651","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
COVID-19患者嗅觉障碍与肺部受累的关系
目的:新型冠状病毒病-2019 (COVID-19)的一些症状在未累及肺部的患者和预后良好的患者中更为常见。虽然已知嗅觉障碍在预后良好的患者中更为常见,但其与肺部受累的关系尚不清楚。本研究探讨了COVID-19患者嗅觉障碍与肺部受累的关系。方法:本横断面研究于2022年5月至2022年7月期间进行,包括60例肺部受累的COVID-19患者和60例未肺部受累的COVID-19患者。在确诊后1个月对所有患者进行电话访谈,并通过问卷调查对其嗅觉进行调查。研究人员询问了嗅觉障碍的患病率、嗅觉障碍的类型和严重程度,并要求参与者从0到10给他们的答案打分。结果:58例(48.3%)患者存在嗅觉障碍。其中35例(60.34%)出现低嗅觉,23例(39.66%)出现嗅觉缺失。20例(33.3%)肺部受累患者存在嗅觉障碍,38例(63.3%)无肺部受累患者存在嗅觉障碍。在没有肺部受累的患者中,嗅觉障碍的患病率明显更高(p=0.001)。肺部受累患者出现15例(25%)低通气,5例(8.3%)嗅觉缺失。无肺受累的患者有20例(33.3%)低通气,5例(8.3%)嗅觉缺失。没有肺部受累的患者嗅觉缺失的患病率明显更高(p=0.003)。未累及肺部的患者嗅觉障碍更为严重(p=0.042)。结论:与肺部受累患者相比,COVID-19无肺部受累患者嗅觉障碍出现的频率和严重程度更高。伊斯坦布尔Haseki培训和研究医院医学公报版权所有©2022。Galenos Yayinevi出版的Haseki医学公报。
本文章由计算机程序翻译,如有差异,请以英文原文为准。